We are live on
!
Find out more
NVO
Novo Nordisk
NVO
NVO
529 hedge funds and large institutions have $10.5B invested in Novo Nordisk in 2016 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 159 increasing their positions, 217 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
4% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 47
2% more call options, than puts
Call options by funds: $24.1M | Put options by funds: $23.6M
0.35% more ownership
Funds ownership: 19.07% → 19.42% (+0.35%)
1% less capital invested
Capital invested by funds: $10.7B → $10.5B (-$154M)
1% less funds holding
Funds holding: 535 → 529 (-6)
4% less funds holding in top 10
Funds holding in top 10: 25 → 24 (-1)
27% less repeat investments, than reductions
Existing positions increased: 159 | Existing positions reduced: 217
Holders
529
Holders Change
-6
Holders Change %
-1.12%
% of All Funds
14.12%
Holding in Top 10
24
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-4%
% of All Funds
0.64%
New
49
Increased
159
Reduced
217
Closed
47
Calls
$24.1M
Puts
$23.6M
Net Calls
+$457K
Net Calls Change
-$2.4M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$134M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$94.9M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$86.4M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$38.7M |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
+$24.7M |
